title: GLP-1 receptor agonist effects on normal and neoplastic pancreata.
authors.forename: Michael
authors.initials: M
authors.lastname: Goggins
mesh_terms: D000818:Animals; D000077270:Exenatide; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives* / Q000633:toxicity; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D000069450:Liraglutide; D008297:Male; D010179:Pancreas / Q000187:drug effects*; D010183:Pancreatic Ducts / Q000187:drug effects*; D010195:Pancreatitis / Q000139:chemically induced*; D010455:Peptides / Q000494:pharmacology*; D016283:Proto-Oncogene Proteins p21(ras) / Q000378:metabolism*; D018027:Receptors, Glucagon / Q000819:agonists*; D014688:Venoms / Q000494:pharmacology*
chemical_list: C000593833:GLP1R protein, human; C000593834:Glp1r protein, mouse; D000067757:Glucagon-Like Peptide-1 Receptor; D007004:Hypoglycemic Agents; D010455:Peptides; D018027:Receptors, Glucagon; D014688:Venoms; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide; C495971:Hras protein, mouse; D016283:Proto-Oncogene Proteins p21(ras)